TABLE 2.
Antimicrobial susceptibility patterns of the five GIM-1 producer isolates from Dusseldorf, Gemany, submitted to the SENTRY Antimicrobial Surveillance Program in 2002
| Antimicrobial agents | MIC (μg/ml) for strain:
|
||||||
|---|---|---|---|---|---|---|---|
| P. aeruginosa 73-5671 | P. aeruginosa 73-12198 | P. aeruginosa 73-15553 | P. aeruginosa 73-15574 | P. aeruginosa 73-15480 | E. coli DH5α(pGIM-1) | E. coli DH5α(pSCRIPT) | |
| Piperacillin | >128 | >128 | >128 | >128 | >128 | 16 | 0.5 |
| Piperacillin-tazobactam | >64 | >64 | >64 | >64 | >64 | - | - |
| Ticarcillin | >128 | >128 | >128 | >128 | >128 | - | - |
| Ticarcillin-clavulanic acid | >128 | >128 | >128 | >128 | >128 | - | - |
| Ceftriaxone | >32 | >32 | >32 | >32 | >32 | 128 | 0.125 |
| Ceftazidime | >16 | >16 | >16 | >16 | >16 | 256 | 0.125 |
| Cefepime | 16 | 16 | >16 | 16 | 16 | 4 | 0.06 |
| Imipenem | >8 | >8 | >8 | >8 | >8 | 0.5 | 0.06 |
| Meropenem | >8 | >8 | >8 | >8 | >8 | 0.125 | 0.06 |
| Aztreonam | 8 | 8 | 16 | 16 | 16 | 0.125 | 0.06 |
| Ciprofloxacin | >4 | >4 | >4 | >4 | >4 | - | - |
| Levofloxacin | >4 | >4 | >4 | >4 | >4 | - | - |
| Gatifloxacin | >4 | >4 | >4 | >4 | >4 | - | - |
| Amikacin | 4 | 4 | 16 | 16 | 16 | - | - |
| Gentamicin | >8 | >8 | >8 | >8 | >8 | - | - |
| Tobramycin | 16 | 16 | >16 | 16 | >16 | - | - |
| Netilmicin | >32 | >32 | >32 | >32 | >32 | - | - |
| Tetracycline | >8 | >8 | >8 | >8 | >8 | - | - |
| Trimethoprim-sulfamethoxazole | >2 | >2 | >2 | >2 | >2 | - | - |
| Polymyxin B | 2 | 2 | 4 | 1 | 1 | - | - |
a
-, Not tested.